Candriam S.C.A. Cytokinetics Inc Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

A detailed history of Candriam S.C.A. transactions in Cytokinetics Inc stock. As of the latest transaction made, Candriam S.C.A. holds 179,200 shares of CYTK stock, worth $8.78 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

179,200

Previous 179,200 -0.0%

Holding current value

$8.78 Million

Previous $9.71 Million 2.55%

% of portfolio

0.06%

Previous 0.06%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$47.86 - $75.05 $15 Million - $23.6 Million	-313,829 Reduced 63.65%	179,200 $9.71 Million
Q1 2024 May 03, 2024	BUY	$63.75 - $108.06 $14.4 Million - $24.4 Million	225,789 Added 84.49%	493,029 $34.6 Million
Q4 2023 Feb 14, 2024	SELL	$26.88 - $83.49 $6.34 Million - $19.7 Million	-236,000 Reduced 46.9%	267,240 $22.3 Million
Q3 2023 Nov 13, 2023	SELL	$29.46 - $36.61 $1.03 Million - $1.28 Million	-35,000 Reduced 6.5%	503,240 $14.8 Million
Q1 2023 May 12, 2023	BUY	$33.36 - $45.71 $1.17 Million - $1.6 Million	35,000 Added 6.95%	538,240 $18.9 Million
Q3 2022 Nov 10, 2022	SELL	$38.54 - $54.52 $664,275 - $939,706	-17,236 Reduced 3.31%	503,240 $24.4 Million
Q2 2022 Aug 03, 2022	SELL	$33.93 - $48.92 $4.06 Million - $5.86 Million	-119,752 Reduced 18.7%	520,476 $20.4 Million
Q1 2022 May 13, 2022	BUY	$29.74 - $46.0 $3.77 Million - $5.84 Million	126,884 Added 24.72%	640,228 $23.6 Million
Q2 2021 Jul 20, 2021	BUY	$19.79 - $26.99 $2.72 Million - $3.71 Million	137,491 Added 36.58%	513,344 $10.2 Million
Q4 2020 Jan 22, 2021	BUY	$15.26 - $28.61 $3.6 Million - $6.74 Million	235,628 Added 168.04%	375,853 $7.81 Million
Q3 2020 Oct 19, 2020	BUY	$20.58 - $28.96 $2.89 Million - $4.06 Million	140,225 New	140,225 $3.04 Million

Others Institutions Holding CYTK

# of Institutions

410

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.61B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account